Cite
HARVARD Citation
Ellingson, B. et al. (2018). Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro-oncology. 20 (9), pp. 1240-1250. [Online].